Bronfman E.L. Rothschild L.P. increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 78.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,886 shares of the medical instruments supplier’s stock after buying an additional 5,236 shares during the period. Bronfman E.L. Rothschild L.P.’s holdings in DENTSPLY SIRONA were worth $771,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of XRAY. Alps Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 0.3% in the second quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 20 shares in the last quarter. Ropes Wealth Advisors LLC boosted its position in shares of DENTSPLY SIRONA by 0.3% in the first quarter. Ropes Wealth Advisors LLC now owns 9,003 shares of the medical instruments supplier’s stock worth $562,000 after buying an additional 29 shares in the last quarter. Wetherby Asset Management Inc. boosted its position in shares of DENTSPLY SIRONA by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock worth $324,000 after buying an additional 30 shares in the last quarter. HighTower Advisors LLC boosted its position in shares of DENTSPLY SIRONA by 0.6% in the first quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock worth $424,000 after buying an additional 39 shares in the last quarter. Finally, Atria Investments LLC boosted its position in shares of DENTSPLY SIRONA by 1.5% in the second quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock worth $294,000 after buying an additional 68 shares in the last quarter. 93.97% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Inc. (XRAY) traded up 0.41% on Thursday, reaching $55.90. The company had a trading volume of 196,203 shares. DENTSPLY SIRONA Inc. has a 12 month low of $52.53 and a 12 month high of $65.68. The firm has a 50 day moving average price of $59.93 and a 200-day moving average price of $62.08. The stock’s market capitalization is $12.83 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.65. The company had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business’s revenue was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.76 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be issued a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/bronfman-e-l-rothschild-l-p-buys-5236-shares-of-dentsply-sirona-inc-xray/1534243.html.

A number of research analysts have recently weighed in on XRAY shares. Goldman Sachs Group Inc cut DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and dropped their price target for the company from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. BidaskClub lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a research note on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. Finally, Credit Suisse Group reaffirmed an “outperform” rating and issued a $75.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company. DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $66.08.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.